Septerna (SEPN) Other Accumulated Expenses (2023 - 2026)
Septerna (SEPN) recorded quarterly Other Accumulated Expenses of $363000.0 in Q1 2026, up 145.27% quarter-over-quarter from $148000.0 in Q4 2025, and up 390.54% on a YoY basis from $74000.0 in Q1 2025.
Septerna (SEPN) Other Accumulated Expenses (2023 - 2026) Analysis & Trends
Septerna's Other Accumulated Expenses history runs 4 years deep, the most recent figure standing at $363000.0 for Q1 2026.
- In Q1 2026, Other Accumulated Expenses rose 390.54% year-over-year to $363000.0; the TTM figure through Mar 2026 stood at $363000.0 (up 390.54% YoY), while the FY2025 annual figure was $148000.0, up 89.74% from the prior year.
- Other Accumulated Expenses was $363000.0 for Q1 2026 at Septerna, up from $148000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $363000.0 in Q1 2026 to a low of $74000.0 in Q1 2025.
- Historically, Other Accumulated Expenses has averaged $134625.0 across 4 years, with a median of $98500.0 in 2023.
- The sharpest annual moves came in 2025 and 2026: Other Accumulated Expenses retreated 16.42% in 2025, then jumped 390.54% in 2026.
- A 4-year view of Other Accumulated Expenses shows it stood at $85000.0 in 2023, then dropped by 8.24% to $78000.0 in 2024, then jumped by 89.74% to $148000.0 in 2025, then soared by 145.27% to $363000.0 in 2026.
- The last three Other Accumulated Expenses figures came in at $363000.0 (Q1 2026), $148000.0 (Q4 2025), and $112000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 363,000.00 |
| Dec 31, 2025 | 148,000.00 |
| Sep 30, 2025 | 112,000.00 |
| Jun 30, 2025 | 83,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | 78,000.00 |
| Sep 30, 2024 | 134,000.00 |
| Dec 31, 2023 | 85,000.00 |